欧洲《粪菌移植临床应用和操作共识报告》介绍

Brief Introduction of European Consensus Report on Clinical Applications and Procedures of Fecal Microbiota Transplantation

粪菌移植(FMT)是将健康人粪便中的功能菌群通过一定方式移植至患者肠道内,从而调节紊乱的肠道菌群,重建肠道微生态系统。除应用于复发性难辨梭菌感染外,FMT对其他菌群失调相关疾病的作用尚不明确且有争议。本文就《Alimentary Pharmacology and Therapeutics》杂志2017年发表的欧洲《粪菌移植临床应用和操作共识报告》作一简介,以期为FMT在我国能更好地服务于临床提供参考。

Fecal microbiota transplantation（ FMT） is to transplant the functional flora from feces of healthy donor into the intestinal tract of patient through a certain approach for improving the microbial dysbiosis of gut and reconstructing the intestinal microecosystem. To date,apart from the application of FMT in recurrent Clostridium difficile infection,the effect of FMT on other dysbiosis-associated diseases is not clear and is controversial. In this article,a brief introduction was done on ＂Consensus report： faecal microbiota transfer-clinical applications and procedures ＂published by the Alimentary Pharmacology and Therapeutics in 2017,which may provide a reference for the further applications of FMT in clinical practice in China.